Pfizer Inc [PFE] stock prices are down -0.49% to $26.62 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PFE shares have gain 2.35% over the last week, with a monthly amount glided 0.23%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research started tracking the stock with Underperform rating on November 15, 2024, and set its price target to $25. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $32 on October 17, 2024. Daiwa Securities upgraded its rating to a Outperform. Argus downgraded its rating to Hold for this stock on March 22, 2024. In a note dated February 23, 2024, Guggenheim initiated an Buy rating and provided a target price of $36 on this stock.
The stock price of Pfizer Inc [PFE] has been fluctuating between $24.48 and $31.54 over the past year. Currently, Wall Street analysts expect the stock to reach $32.17 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $26.62 at the most recent close of the market. An investor can expect a potential return of 20.85% based on the average PFE price forecast.
Analyzing the PFE fundamentals
The Pfizer Inc [NYSE:PFE] reported sales of 60.11B for trailing twelve months, representing a surge of 33.78%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.44 points at the first support level, and at 26.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.94, and for the 2nd resistance point, it is at 27.25.
Ratios To Look Out For
It’s worth pointing out that Pfizer Inc [NYSE:PFE]’s Current Ratio is 1.00. As well, the Quick Ratio is 0.73, while the Cash Ratio is 0.03. Considering the valuation of this stock, the price to sales ratio is 2.51, the price to book ratio is 1.63 and price to earnings (TTM) ratio is 35.78.
Transactions by insiders
Recent insider trading involved Gottlieb Scott, Director, that happened on Oct 30 ’24 when 1000.0 shares were purchased. SVP & Controller, DAMICO JENNIFER B. completed a deal on Aug 13 ’24 to sell 5154.0 shares.
